Mechanism of coordinated access to orphan drugs

Mechanism of coordinated access to orphan drugs

Bibliographic Details
Main Authors:	DeRidder R, Adriaens C, Kleinermans D, Mortier M, Quanten A, Arickx F
Format:	Article
Language:	English
Published:	BMC 2012-11-01
Series:	Orphanet Journal of Rare Diseases

Similar Items

Patient access to orphan drugs in France
by: Marion Bourdoncle, et al.
Published: (2019-02-01)

Analysis of patient access to orphan drugs in Turkey
by: Güvenç Koçkaya, et al.
Published: (2021-02-01)

Market access of orphan drugs and the role of multi-criteria decision making
by: Simoens Steven
Published: (2012-11-01)

Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China
by: Xiao-Qiao Li, et al.
Published: (2018-01-01)

Estimating the clinical cost of drug development for orphan versus non-orphan drugs
by: Kavisha Jayasundara, et al.
Published: (2019-01-01)

Googlizing a Digital Library
by: Jody DeRidder
Published: (2008-03-01)

EVOLUTION OF ACCOUNTING SINCE LUCA PACIOLO
by: Jerome DeRidder
Published: (2005-06-01)

WHAT ON EARTH HAPPENED TO THE ACCOUNTING PROFESSION (ABSTRACT)
by: Jerome DeRidder
Published: (2004-06-01)

WHAT ON EARTH HAPPENED TO THE ACCOUNTING PROFESSION (ABSTRACT)
by: Jerome DeRidder
Published: (2004-06-01)

EVOLUTION OF ACCOUNTING SINCE LUCA PACIOLO
by: Jerome DeRidder
Published: (2005-06-01)

Rare Diseases and Difficulty Accessing Orphan Drugs: A Topic That Needs Discussion
by: José Pedro Vieira
Published: (2021-04-01)

Coordinated orphan disease research: yes, we can!
by: Olivier M. Vanakker
Published: (2013-11-01)

Risk and reward in the orphan drug industry
by: Lo, A.W, et al.
Published: (2019)

Excluding Orphan Drugs from the 340B Drug Discount Program: the Impact on 18 Critical Access Hospitals
by: Madeline Carpinelli Wallack, et al.
Published: (2012-01-01)

Sex-related roles, attitudes, and orientation of Negro, Anglo, and Mexican-American women over the life cycle
by: DeRidder, Joyce A.
Published: (1976)

Rare diseases and orphan drugs
by: Domenica Taruscio, et al.
Published: (2011-01-01)

Predictors of orphan drug approval
by: Heemstra Harald
Published: (2010-10-01)

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries.
by: Todd Gammie, et al.
Published: (2015-01-01)

Expenditure trends of orphan drugs in Serbia: 8-Year analysis of orphan drug market in Serbia
by: Pejčić Ana V., et al.
Published: (2016-01-01)

Generating Standardized Audio Technical Metadata: AES57
by: Jody L. DeRidder
Published: (2015-10-01)

Benign Neglect: Developing Life Rafts for Digital Content
by: Jody L. DeRidder
Published: (2011-06-01)

First Aid Training for Those on the Front Lines: Digital Preservation Needs Survey Results 2012
by: Jody L. DeRidder
Published: (2013-06-01)

Analysis of a non-contact laser-fiber optic array for generation of ultrasound
by: DeRidder, W. Nick
Published: (2007)

Excluding Orphan Drugs from the 340B Drug Discount Program: the Impact on 18 Critical Access Hospitals
by: Madeline Carpinelli Wallack, et al.
Published: (2012-01-01)

Comparing access to orphan medicinal products in Europe
by: Bernarda Zamora, et al.
Published: (2019-05-01)

Financing drug discovery for orphan diseases
by: Gromatzky, Austin A., et al.
Published: (2014)

Precision Medicines’ Impact on Orphan Drug Designation
by: Christine M. Mueller, et al.
Published: (2019-11-01)

The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America [v1; ref status: indexed, http://f1000r.es/3ix]
by: Renée J.G. Arnold, et al.
Published: (2015-02-01)

Orphan drugs assessment in the centralised procedure
by: Giuseppe Nisticò
Published: (2011-01-01)

Are payers treating orphan drugs differently?
by: Joshua P. Cohen, et al.
Published: (2014-01-01)

What Is the Purpose of the Orphan Drug Act?
by: Matthew Herder
Published: (2017-01-01)

Orphan drug: Development trends and strategies
by: Aarti Sharma, et al.
Published: (2010-01-01)

Similarity in the context of the orphan drug legislation
by: Pereira Franco, Joao Pedro
Published: (2015)

New mechanism-based anticancer drugs that act as orphan nuclear receptor agonists
by: Chintharlapalli, Sudhakar Reddy
Published: (2007)

Metadata In, Library Out. A Simple, Robust Digital Library System
by: Tonio Loewald, et al.
Published: (2010-06-01)

DEVELOPMENT OF THE ACCOUNTING PROFESSION IN MARYLAND (ABSTRACT)
by: Jerome DeRidder, et al.
Published: (1999-06-01)

Pricing of orphan drugs in oncology and rare diseases
by: Mark Nuijten, et al.
Published: (2020-01-01)

DRUG FLURENISID AS AN IMMUNOMODULATOR FOR THE TREATMENT OF ORPHAN DISEASES
by: Мaria Kovalenko
Published: (2017-12-01)

Establishing a reasonable price for an orphan drug
by: Mikel Berdud, et al.
Published: (2020-09-01)

Editorial: Orphan GPCRs as emerging drug targets
by: Ye eFang, et al.
Published: (2015-12-01)